42137-51-9

Basic information

• Product Name: Benzoic acid, 4-formyl-2-hydroxy-, methyl ester
• CAS NO: 42137-51-9
• Molecular Formula: C9H8O4
• Molecular Weight: 180.16
• Mol File: 42137-51-9.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-formyl-2-hydroxy-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-formyl-2-hydroxy-, methyl ester(42137-51-9)
• EPA Substance Registry System: Benzoic acid, 4-formyl-2-hydroxy-, methyl ester(42137-51-9)

Safety Data

• Hazardous Substances Data: 42137-51-9(Hazardous Substances Data)

Upstream product

• 1571-08-0 methyl 4-formylbenzoate 
• 18179-39-0 methyl 4-iodosalicylate 
• 194018-68-3 vanillin triflate 
• 121-33-5 vanillin 
• 71534-96-8 2-hydroxy-4-vinyl-benzoic acid methyl ester 
• 55204-14-3 methyl 4-formyl-2-methoxybenzoate 
• 53343-59-2 Methyl cyclohepta-1,3,5-triene-2-carboxylate 

Downstream Products

• 1356059-97-6 2-hydroxy-4-(2-oxo-5,6-diphenyl-1,2,3,4-tetrahydropyridin-4-yl)benzoic acid 
• 1356060-17-7 2-hydroxy-4-(2-oxo-6-phenyl-5-(thiophen-3-yl)-1,2,3,4-tetrahydropyridin-4-yl)benzoic acid 
• 1356059-98-7 2-hydroxy-4-(6-(1-methyl-1H-pyrazol-4-yl)-2-oxo-5-(thiophen-3-yl)-1,2,3,4-tetrahydropyridin-4-yl)benzoic acid 
• 42137-52-0 4-{[2,2-dimethoxy-ethylimino]-methyl}-2-hydroxy-benzoic acid methyl ester 
• 51572-88-4 4-formyl-2-hydroxybenzoic acid 
• 1283119-63-0 2-hydroxy-4-(6-(1-methyl-1H-pyrazol-4-yl)-2-phenyl-1,2,3,4-tetrahydropyrimidin-4-yl)benzoic acid 
• 1283119-46-9 2-hydroxy-4-(2-oxo-5-phenyl-6-(pyridin-3-yl)-1,2,3,4-tetrahydropyrimidin-4-yl)benzoic acid 
• 1283118-81-9 2-hydroxy-4-(2-oxo-5,6-diphenyl-1,2,3,4-tetrahydropyrimidin-4-yl)benzoic acid 
• 1283119-64-1 (R)-2-hydroxy-4-(6-(1-methyl-1H-pyrazol-4-yl)-2-oxo-5-(thiophen-3-yl)-1,2,3,4-tetrahydropyrimidin-4-yl)benzoic acid 
• 1283119-65-2 (S)-2-hydroxy-4-(6-(1-methyl-1H-pyrazol-4-yl)-2-oxo-5-(thiophen-3-yl)-1,2,3,4-tetrahydropyrimidin-4-yl)benzoic acid 
• 1283119-44-7 2-hydroxy-4-(6-(1-methyl-1H-pyrazol-4-yl)-2-oxo-5-(thiophen-3-yl)-1,2,3,4-tetrahydropyrimidin-4-yl)benzoic acid 
• 1283118-83-1 ethyl 2-hydroxy-4-(2-oxo-5,6-diphenyl-1,2,3,4-tetrahydropyrimidin-4-yl)benzoate 
• 926634-53-9 2-hydroxy-4-(1-hydroxy-butyl)-benzoic acid methyl ester 
• 80235-10-5 2-hydroxy-4-(hydroxymethyl)benzoic acid methyl ester 

Relevant articles and documents

NMDA RECEPTOR MODULATORS AND USES RELATED THERETO

This disclosure relates to NMDA modulators and used related thereto such as for treatment of central nervous system disorders. In certain embodiments, compounds disclosed herein are NR2C subunit-selective NMDA potentiators. In certain embodiments, the disclosure contemplates compounds and pharmaceutical compositions. In certain embodiments, the disclosure contemplates compounds disclosed herein as prodrugs, optionally substituted with one or more substituents, derivatives, or salts thereof. In certain embodiments, the disclosure relates to methods of treating or preventing nervous system disorders comprising administering an effective amount of a composition comprising compound disclosed herein to a subject in need thereof.

ALKOXY PYRAZOLES AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6 and R7 are as defined herein. The inventi

Compounds and Compositions as Tpo Mimetics

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TPO activity, particularly disea